Member Info for r0h1td

27-Oct-20 09:38:27 0.44 83,000,000 Unknown* 0.43 0.45 365.20k

From experience, all big rises are initially held back. I think this is a good sign of a steady re-rate especially off the back of the Covid investment and high calibre parties involved. OMI was too tightly held back in the 16 - 18p range before it was let loose and then strongly rose to 45p. I feel the same will surely happen here soon with a first target of mid 0.2's.
Here's hoping . . .

14-Sep-20 15:29:59 0.05 10,015,871 Buy* 0.014 0.0155 5,008

hmmm

Target - 1p
Im in.

Vote required. Need to raise capital, they can't do so, 1p S/P required.

Solid contracts, US contracts. Should see a good uplift today.

They also raised £2.24 million at the same price 3 months back.

TODAY'S PRICE 0.06pence!!!

Further to the announcements on 27 October 2019, 5 March 2020 and 20 March 2020, the Company has completed the acquisition of Supply@ME S.r.l., a business which has developed an alternative FinTech platform focussed on inventory monetisation facilities, which can enable a wide range of manufacturing and trading businesses to improve their working capital position and provide a new asset class to investors. Consideration for the acquisition is £224.5 million to be satisfied by the issue of 32,332,246,220 Consideration Shares at a price of 0.69 pence per share ("the Acquisition").

The Acquisition constitutes a reverse takeover under the Listing Rules for Companies and, as previously announced, shares in the enlarged company will be admitted to the Standard Segment of The Official List and to trading on the London Stock Exchange's Main Market at 8.00 a.m. today under the ticker "SYME" ("Admission"). The ISIN of the Ordinary Shares is GB00BFMDJC60 and the SEDOL Code is BFMDJC6. Following completion of the acquisition, the Company has now changed its name to Supply@ME Capital plc and its website can be found at the following link: www.supplymecapital.com.

In conjunction with the Acquisition, the Company has raised £2.24 million, before expenses, through the issue of 331,604,094 Placing Shares in the Company at a price of 0.68 pence per share to certain investors ("the Placing"). A total of £42.18 million of Ordinary Shares were placed through the Placing and Vendor Placing with institutional and other investors.

. . . . funding from turnaround specialist Hilco Capital.
Note, turnaround specialists.

Where will it go??

Only 1% needed. Biodegradable and Corona hostile including other bacteria, viruses and fungi.
Funny thing is MBO reached a Market Cap of exactly where we a sitting on nothing yesterday.
This is a major breakthrough and an essential product for the current times.
I'm holding long.

Draft - stuck a bit in MAC too just now. Lets see.

Greencastle has been informed by the Examiner and the Joint Administrators that, after consideration of Greencastle's indicative bid, it has been taken through into the respective second and final rounds. The next step in the process is discussions with management and final due diligence, which is expected to take place this week.

If the Greencastle bid is successful, Iconic Labs and Greencastle intend to enter into a management services agreement whereby Iconic will manage the JOE assets. Negotiations in respect of this management agreement are taking place, but there can be no assurance that either the Greencastle bid will ultimately be successful or that terms for a management services agreement will be agreed.

(Alliance News) - Mediazest PLC on Monday said its results for the six months to March showed a "particularly pronounced" impact from the Covid-19 pandemic.

Since then, Mediazest said it has been able to deliver two previously delayed projects.

Shares in the company more than doubled at 0.060 pence each in London after the market close on Monday.

In the six months to March 31, its year-end date, the London-based audio visual services provider said it generated GBP1.5 million in revenue and earnings before interest, taxes, depreciation, and amortisation of GBP57,000.

"The impact of the Pandemic was particularly pronounced on the group's financial results for March 2020 as projects had been put on hold due to the lockdown. The group estimates that the adverse impact on the business within the six months was to reduce revenue by approximately GBP200,000 and profit by GBP80,000.

"The group is pleased to now note that as the lockdown has been eased across many countries, further client sites have re-opened and in May 2020, MediaZest delivered on two of the previously delayed projects. There are several other projects now similarly scheduled for completion in June 2020 and the board expects that all previously delayed projects will be delivered in the coming weeks."

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Could be becoming one

London, 01 June 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that, in compliance with the Medical Device Directive ("MD Directive") and having met the stringent criteria associated with the manufacture of a medical device, it has affixed a CE Mark to Bleepa. Bleepa is Feedback's flagship imaging-based communication platform for clinicians to access medical grade images through smartphones, tablets and desktops.



All clinical communication platforms that display digital images of patients for the purpose of diagnosis are classed as medical devices under the MD Directive guidelines and require a CE mark. The Directors of Feedback believe that Bleepa is the only communication platform to address the UK market that has met MD Directive certification requirements.



The Directors also believe that having a CE mark is a major step forward for the Bleepa product since the use of a non-CE marked product inappropriately may put individual clinicians and Trusts at risk of civil claims for damages arising from misuse of that product. For this reason the Medicines & Healthcare products Regulatory Agency ("MHRA") advise that all providers only use appropriately CE marked devices.

Thanks LB28
Yes, i would have thought wait and hold AF for a while too.
Considering the jump in price towards the end, looks like the 2's are coming.

Could someone confirm pls:-
- All assets sold apart from Austin Field which also looks like it will be sold for cash.
- Over £1M in cash + whatever they get for AF
- Cash shell looking for a new T/O opportunity
- New management to be announced including strategic plan

Seems to me like the raise is to gear up and deliver

26 May 2020
Peel Hunt today reaffirms its buy investment rating on Marston's PLC (LON:MARS) and raised its price target to 95p (from 60p).